- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
AcelRx Pharmaceuticals (NASDAQ:ACRX), Quotes and News Summary
AcelRx Pharmaceuticals (NASDAQ: ACRX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-15 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.060 | -0.060 | 0.0000 | ||||
| REV | 550.000K | 442.000K | -108.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
AcelRx Pharmaceuticals Questions & Answers
You can purchase shares of AcelRx Pharmaceuticals (NASDAQ: ACRX) through any online brokerage.
Other companies in AcelRx Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for AcelRx Pharmaceuticals (NASDAQ: ACRX) was reported by HC Wainwright & Co. on Monday, March 14, 2022. The analyst firm set a price target for 0.00 expecting ACRX to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for AcelRx Pharmaceuticals (NASDAQ: ACRX) is $0.2443 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for AcelRx Pharmaceuticals.
AcelRx Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for AcelRx Pharmaceuticals.
AcelRx Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.